Biomarkers of Kidney Injury and Klotho in Patients with Atherosclerotic Renovascular Disease
Year: 2014
Type: article
Study design: Observational Study
Abstract: BACKGROUND AND OBJECTIVES: Occlusive renovascular disease and hypertension may progress to CKD. Circulating levels of several biomarkers, including fibroblast growth factor (FGF)-23, Klotho, and soluble urokinase plasminogen activator receptor (suPAR), are altered in patients with CKD, but their role in essential hypertension (EH) and renovascular hypertension (RVH) remains unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Levels of FGF-23, Klotho, suPAR, plasminogen activator inhibitor (PAI)-1, tissue factor, and tissue factor pathway inhibitor (TFI) were measured in the inferior vena cava and renal vein of hypertensive patients with atherosclerotic renal artery stenosis (n=12) or age-matched participants with EH (n=12) and relatively preserved renal function. Single-kidney blood flow was measured to calculate renal release of markers. For control, peripheral vein levels were measured in healthy volunteers (HVs; n=12). RESULTS: FGF-23 levels did not differ among the groups, whereas Klotho levels were lower in participants with RVH and EH than in HVs, and suPAR levels were elevated in patients with RVH compared with HVs and patients with EH (6.1±1.5 versus 4.4±1.9 and 3.2±1.2 ng/ml, P<0.05). PAI-1 levels were higher in patients with RVH than in patients with EH, but tissue factor and TFI levels were not statistically significantly different. After adjustment for GFR, Klotho levels remained decreased in both RVH and EH, and suPAR and PAI-1 levels remained elevated in RVH. eGFR correlated inversely with systemic and renal vein suPAR levels, and directly with systemic Klotho levels. CONCLUSIONS: Klotho levels are low in hypertensive patients, whereas suPAR and PAI-1 levels are specifically elevated in RVH, correlating with GFR. Klotho, PAI-1, and suPAR may be markers of kidney injury in hypertensive patients.
DOI: 10.2215/cjn.07290714
Institutions: Soonchunhyang University, Mayo Clinic
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: Klotho, soluble urokinase plasminogen activator receptor, plasminogen activator inhibitor-1, kidney injury biomarkers, atherosclerotic renal artery stenosis, renovascular hypertension, essential hypertension, chronic kidney disease, glomerular filtration rate, extrinsic coagulation pathway, fibroblast growth factor 23
Open Access status: green
Awards: Hypoxia and inflammatory injury in human renovascular hypertension, Ultrasound Shockwave Therapy for Post-Stenotic Microvascular Remodeling, Noninvasive assessment of renal fibrosis using magnetization transfer MRI, Mayo Clinic Center for Clinical and Translational Science (CCaTS), CT imaging for the assessment of kidney injury distal to renal artery stenosis, Low-Energy Shockwave Treatment Distal To Peripheral Vascular Disease, Lp-PLA2 and Coronary Atherosclerosis in Humans, EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM
OpenAlex ID: W2098073856
